Officials in the US government health department have approved a new drug for the treatment of Alzheimer’s disease after nearly 20 years of deliberation. The Food and Drug Administration (FDA) has said that approval is being given to using the drug developed by the Biogen company.
Alzheimer’s is a progressive disease of the brain in which the sufferer loses control over the body. The FDA has said that the new drug will help slow down the effects of the disease. Also, its side effects will also be less. This decision will bring great relief to millions of older American citizens and their families.
This new drug has been developed by Biogen in collaboration with Isai Company of Japan. This will not compensate for the damage done to the brain, but it will certainly slow down the rate of damage in the future. This medicine has to be given once every four weeks. Some experts believe that dementia patients will also benefit from this drug. This will reduce the speed of memory loss in them.